ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
"PHARMENA" SPÓŁKA AKCYJNA: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
3.115M{"amount": 3115000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Metric
- cashflow_financing
- Period
- 2020-01-01 – 2020-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:259400RHT936BBKW0955:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:39:51.631039+02:00
Raw response SHA-256
53d3b7a4c3a6a6f02eef738c2cfa312e…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.